Voltaren Gel

Quick links to important sections

Voltaren Gel

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Voltaren Gel

Quick Facts

Property Description
Active ingredient Diclofenac sodium
Form Topical gel (Semisolid preparation)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Localized relief from pain and inflammation
Origin Synthetic substance (Phenylacetic acid derivative)

Understanding Its Pharmacological Identity

The medicinal entity marketed as Voltaren Gel is a topical analgesic and anti-inflammatory pharmaceutical preparation. Its active ingredient is Diclofenac sodium, which is firmly classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This compound is a synthetic substance—a phenylacetic acid derivative—and functions as a single-ingredient product. The formulation’s unique status is clinically recognized for providing the therapeutic benefits of a powerful NSAID through a method other than oral ingestion, setting it apart from common systemic pain relievers.

The identity as an NSAID establishes its core function: to inhibit the specific biological pathways that lead to inflammation and pain. Unlike systemic NSAID dosage forms that distribute the active substance throughout the entire body, this preparation focuses the action of Diclofenac sodium on a localized area, which is paramount in addressing musculoskeletal discomfort, such as tenderness in the joints or soft tissues.


Topical Gel Formulation and Its Purpose

The medicine is physically a topical gel, a specialized semisolid preparation designed for cutaneous application. This formulation incorporates a sophisticated hydroalcoholic vehicle that is essential for its function, ensuring efficient percutaneous absorption of the active compound through the skin. The active substance, diclofenac, is absorbed through the skin, resulting in accumulation in the underlying tissues.

This targeted delivery allows the Diclofenac sodium to penetrate effectively to the underlying soft tissues and joints. The principal purpose of this specific topical delivery is to provide precise localized relief from inflammation and stiffness. By delivering the NSAID locally, the preparation is engineered to provide the powerful anti-inflammatory action and concurrent analgesic effect at the site of discomfort, supporting its role as a targeted solution for localized symptoms.

Regulatory References

  1. Diclofenac Topical (arthritis pain): MedlinePlus Drug Information

What side effects are possible with Voltaren Gel?

Possible Side Effects and Safety Information

The safety profile of topical diclofenac gel is predominantly characterized by localized reactions at the application site, while also including warnings for systemic adverse reactions associated with the Nonsteroidal Anti-inflammatory Drug (NSAID) class. The overall risk profile is guided by official documentation from regulatory agencies such as the FDA and EMA.


Official Adverse Reaction Classification

The most frequent adverse events involve the Skin and Subcutaneous Tissue Disorders. Reactions are classified by frequency as follows:

Classification Examples of Documented Reactions
Common Dermatitis (contact, allergic), Pruritus, Rash, Erythema
Rare/Very Rare Bullous dermatitis, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Photosensitivity reaction, Angioedema

Serious adverse reactions documented in regulatory sources include the potential for Systemic Hypersensitivity Reactions and Asthma precipitation in susceptible patients. Warnings for serious NSAID-related risks—such as Gastrointestinal Ulceration/Bleeding and Cardiovascular Thrombotic Events—are included, reflecting the drug’s pharmacological identity.


Population and Exposure Constraints

Official labeling contains specific constraints. The medication is Contraindicated in the third trimester of pregnancy due to the risk of fetal harm. Furthermore, it is restricted for use in patients with a history of NSAID-induced asthma or other severe allergic-type reactions. Regulatory documents note that the potential for systemic adverse effects may increase with long-term use or when the gel is applied over large surface areas of the skin.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose from the topical application of this product is considered unlikely due to its low systemic absorption. However, the official regulatory profile is structured around the potential for systemic Diclofenac poisoning, which primarily arises from the risk of accidental ingestion of the gel.

Systemic overdose may present with documented manifestations affecting the gastrointestinal tract (Nausea, Vomiting, Diarrhea, Stomach pain) and the central nervous system (Dizziness, Drowsiness, Headache). Severe outcomes officially associated with overdose include Gastrointestinal bleeding, Seizures, Coma, and Acute renal failure.


Emergency Response and Management

Critical Manifestation Mandated Help-Seeking
Accidental ingestion of gel Seek medical help right away.
Severe systemic reaction (e.g., Anaphylaxis) Seek emergency help.

The official prescribing information confirms that no specific antidote is known for Diclofenac overdose. Treatment is therefore described as symptomatic and supportive. Management procedures often require hospital monitoring and focus on addressing the clinical signs, including checking for signs of worsening renal function. Caution regarding increased systemic risk applies to vulnerable populations, including the elderly and those with impaired renal function.

Therapeutic Uses of Voltaren Gel

What Voltaren Gel Treats: Main Uses and Benefits

The medication is relevant for managing symptoms associated with inflammatory or degenerative musculoskeletal conditions. The therapeutic domain is aligned with supportive symptom management for conditions where symptoms may intensify temporarily.

This medication is commonly used to help with symptoms related to physical discomfort, such as the localized pain and stiffness associated with Osteoarthritis (OA). It is relevant in conditions presenting with recurrent or episodic manifestations in joints like the knees, hands, and ankles. It is also used to help with pain and swelling following acute episodes like sprains, strains, and contusions.

“It supports the patient during difficult episodes by easing the symptom burden.”

Its application contributes to easing the overall symptom load when managing symptoms that interfere with daily comfort. The medication is relevant in clinical settings that involve acute or disruptive symptom patterns, such as those associated with tendonitis or bursitis, and may assist with maintaining comfort and stability when these localized manifestations become more noticeable.


Quick Fact: Relief for Localized Discomfort The medication is commonly used across conditions presenting with acute episodes or recurrent manifestations, offering supportive relief when symptoms related to inflammatory or irritative states interfere with routine activities.

Regulatory References

  1. NIH StatPearls Overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Voltaren Gel?

The population eligibility for diclofenac topical gel is strictly defined by regulatory documents, primarily based on age, allergy status, and specific underlying conditions. The medicine is contraindicated (absolutely prohibited) for several groups.

Contraindications and Non-Eligibility

Absolute non-eligibility includes individuals with a known hypersensitivity to the active ingredient, diclofenac, or any other NSAIDs or aspirin that caused allergic reactions such as asthma or hives. The gel is also contraindicated for use in the setting of Coronary Artery Bypass Graft (CABG) surgery and must not be used on damaged skin.

Age and Physiological Status: Use is contraindicated in children and adolescents under 14 years of age. For pregnancy, the gel is contraindicated starting at 30 weeks gestation (third trimester). Use during the first and second trimesters and while breastfeeding is generally not recommended unless necessary, and requires conditional application restrictions.

Restricted and Conditional Use

Use is allowed but requires caution and monitoring in elderly patients and those with pre-existing conditions such as impaired renal function, liver dysfunction, or a history of gastrointestinal bleeding. Patients with advanced renal disease or severe heart failure are advised to avoid use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Diclofenac sodium topical gel is primarily structured around interactions that reinforce systemic NSAID-related risks and those that modify the effect of co-administered medicines, as documented in official prescribing information.


Pharmacodynamic and Exposure Interactions

Interacting Medicine Category Official Interaction Statement
Oral Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Concurrent use must be avoided due to the potential for increased systemic adverse effects.
Analgesic Doses of Aspirin Use is not generally recommended due to increased risk of serious gastrointestinal bleeding.
Anticoagulants/Antiplatelets (e.g., Warfarin) Increases the labeled risk of serious gastrointestinal bleeding.
Antihypertensives (e.g., ACE Inhibitors, ARBs) May diminish the antihypertensive effect of these medicines.
Digoxin Can increase serum concentration and prolong the half-life of Digoxin.

Application and Population Restrictions

Topical Products: Other topical products, including sunscreens, cosmetics, lotions, moisturizers, or other topical medications, must be avoided on the treated skin site to prevent potential alteration of drug absorption.

Population Note: The interaction with ACE Inhibitors and ARBs may result in a greater risk of deterioration of renal function in high-risk groups, including the elderly, volume depleted, or those with underlying renal impairment.

Mechanism of Action

Mechanism of Action: Diclofenac


Enzyme Inhibition and Mediator Suppression

The core mechanism of the active ingredient, diclofenac, involves the competitive inhibition of Cyclooxygenase (COX) enzymes, including both the COX-1 and COX-2 isoforms. This molecular action directly suppresses the conversion of arachidonic acid into prostaglandins, which are key biochemical signals involved in the inflammatory process.


️ Multi-Modal Peripheral Nociceptor Modulation

By reducing the amount of sensitizing prostaglandins, the drug decreases the responsiveness of peripheral nociceptors to stimuli. This chemical suppression is augmented by secondary actions that may modulate local ion channels, leading to a dual mechanism that results in a localized suppression of nociceptive signaling.


Mechanistic Constraints of Localized Action

The mechanism's efficacy is dependent on achieving a sustained inhibitory concentration within the deeper, inflamed soft tissues or joint capsule. This physiological constraint means the action remains localized to the peripheral area of application, achieving a targeted modulation of the prostaglandin pathway.

Dosage and Administration Information

The administration of Voltaren Gel (Diclofenac sodium topical gel 1%) is governed by measured application to the skin overlying the affected joint. The approved route is exclusively topical.

Official Dosing and Frequency

The required dose must be accurately measured using the dosing card provided with the product for each application. The application frequency is typically four times daily at regular intervals. Dosing is distinguished by the size of the area being treated:

Joint Location Dose per Application Maximum Daily Dose per Joint
Upper Extremities (Hand, Wrist, Elbow) 2 grams 8 grams
Lower Extremities (Knee, Ankle, Foot) 4 grams 16 grams

The total quantity of gel used across all treated areas must not exceed 32 grams per day. Treatment duration should utilize the lowest effective dosage for the shortest necessary period. For soft-tissue injuries, clinical guidance advises re-evaluation if symptoms have not improved after 7 days, and treatment should not typically exceed 21 days for osteoarthritis.

Procedural and Time-Based Rules

After gently massaging the dose into the skin, the area must not be washed for at least one hour. Furthermore, the application site should remain uncovered by clothing or gloves for at least 10 minutes to facilitate proper absorption. The standard adult dosing regimen applies to the geriatric population. For adolescents aged 14 years and older, use is generally restricted to acute soft-tissue injuries, with a mandate to consult a doctor if the product is required for more than 7 days.

Recent Clinical Evidence

Research evidence / Overview of studies for Diclofenac Topical Gel

Evidence for Use in Osteoarthritis of Superficial Joints

Research for diclofenac topical gel has primarily focused on studies exploring symptom patterns related to Osteoarthritis (OA), particularly when the condition affects joints close to the skin's surface, such as the knees and hands. Research involves short-term, randomized controlled trials (RCTs). Studies described patterns observed in the measured outcomes in the diclofenac gel group and the vehicle gel group. These findings describe group patterns related to how patients reported their experience during the study period. Evidence remains limited regarding the gel's use for OA in deeper joints, like the hip or spine.


Evidence for Use in Acute Musculoskeletal Trauma

Research also examined how the gel was observed in contexts involving acute or disruptive episodes, such as short-term pain and inflammation following minor sprains, strains, and contusions. Studies in this area were often very short-term RCTs. Researchers monitored outcomes like symptom intensity and the time required for symptoms to subside. Studies described patterns observed in the measured outcomes for pain and functional recovery in the diclofenac gel group relative to the non-medicated control gel group. Research has also explored the use of the topical gel, including studies monitoring outcomes alongside oral anti-inflammatory pills.


Long-Term Studies and Follow-Up Data

The research base provides information on the observation periods of the studies. For the treatment of localized OA, the pivotal efficacy trials were primarily short-term, typically observing patients for up to 12 weeks. Beyond these short-term trials, some long-term observational settings have extended follow-up for up to one year. However, long-term effects are not fully established and the durability of symptom patterns beyond that one-year mark remains uncertain in formal controlled research.


What Remains Uncertain: Research Gaps and Study Limitations

Beyond efficacy, research involved Pharmacokinetic (PK) studies and Bioequivalence (BE) studies to monitor the systemic exposure of the active ingredient after topical application. The evidence contributes to the broader evidence landscape for research exploring localized symptom patterns, though several limitations and gaps remain. Data for use in children (under 14 years old) remain limited. One key limitation is that results apply only to the populations studied, which focused heavily on superficial joints like the knees and hands. Limited information for long-term outcomes is available for the topical gel's application to deeper joints.

Key Studies & References

  1. Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled Study
  2. Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A study supporting OTC switch

Frequently Asked Questions (FAQ)

Common questions about Voltaren Gel (FAQ)

Q: Can Voltaren Gel be used by people with a history of stomach ulcers?

Regulatory warnings state that people with a prior history of peptic ulcer disease or gastrointestinal bleeding have a greater risk for serious gastrointestinal events associated with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including those in topical form.

Q: How long does the informational leaflet say the effects of one application may last?

According to the official product information, the gel is typically applied four times daily to the affected joint. This frequency is consistent with the established dosing regimen described in the regulatory guidelines.

Q: What is the difference between Voltaren Gel and oral NSAIDs?

Studies and official information indicate that topical application of the gel results in a much lower concentration of the active ingredient in the bloodstream compared to taking oral NSAIDs. This allows the drug to achieve higher concentrations in the underlying soft tissues and joints where the pain is located.

Q: Can Voltaren Gel be applied to large areas of the body?

Official rules for administration limit the total amount that can be used. The total dose applied across all treated areas is subject to a maximum daily amount, as specified in the official labeling. Furthermore, some regulatory labeling specifies that the product should not be used on more than two body areas at the same time.

Q: Is it safe to go in the sun after applying Voltaren Gel?

Regulatory warnings indicate the potential for a photosensitivity reaction, which means the skin may become more sensitive to sunlight. Official warnings regarding photosensitivity reactions generally recommend avoiding direct sun exposure and using protective measures on the treated area.

Q: Can Voltaren Gel be used on children or teens?

According to official product information, the use of the gel is contraindicated in children and adolescents under 14 years of age. For individuals aged 14 years and older, use is generally restricted to short-term application for acute soft-tissue injuries.

Q: Can Voltaren Gel affect blood pressure?

The active ingredient is an NSAID, which may diminish the effect of certain blood pressure medications, called antihypertensives. Regulatory warnings also note that NSAIDs can increase the risk of heart-related events in people who already have risk factors, such as high blood pressure.

Q: Can people who take blood thinners use Voltaren Gel?

Official information states that concurrent use with anticoagulant and antiplatelet medicines (often called blood thinners) increases the labeled risk of serious gastrointestinal bleeding.

Q: What information is available about using Voltaren Gel with other topical products?

Official labeling states that other topical products (including sunscreens, lotions, and cosmetics) must be avoided on the treated skin area.

Q: Are there known interactions between Voltaren Gel and heart medications?

Regulatory documents list interactions with heart medications such as Antihypertensives and Digoxin. Use is contraindicated (prohibited) for patients recovering from coronary artery bypass graft (CABG) surgery and is not recommended for patients with established severe heart failure.

Q: What are the most commonly reported side effects in studies?

The most frequently reported adverse reactions are localized skin reactions at the application site. These commonly include dermatitis (skin irritation), itching (pruritus), rash, and redness (erythema).

Q: Can Voltaren Gel be used for foot or ankle pain?

The gel is indicated for the relief of pain associated with osteoarthritis in joints that are close to the skin’s surface. Official dosing instructions specify the application amount for joints in the foot and ankle.

Q: Is it only for arthritis, or can it be used for other injuries?

The gel is approved for the treatment of pain related to osteoarthritis in specific joints. Studies have also examined its application in the context of acute episodes, such as minor sprains and strains.

Q: Why is Voltaren Gel prescribed for some people but available without a prescription for others?

Regulatory bodies determine the availability of a medicine based on strength and indication. For example, in the United States, the 1% concentration is approved for over-the-counter use for arthritis pain, while different strengths or formulations may remain prescription-only.

Q: How quickly can a person expect to feel the effects of the gel?

Official labeling states that the product is not for immediate relief. For the treatment of arthritis pain, it may take up to 7 days to begin to provide noticeable relief.

Q: How does Voltaren Gel work only on the applied area?

The topical formulation is designed for percutaneous absorption, meaning it passes through the skin. This allows the active ingredient to accumulate primarily in the underlying soft tissues and joints, achieving targeted action with lower concentrations in the general bloodstream compared to oral NSAIDs.

Q: What kind of studies have been done on Voltaren Gel?

The research includes short-term randomized controlled trials (RCTs) to study symptom patterns in conditions like osteoarthritis. There are also specialized studies, such as pharmacokinetic (PK) and bioequivalence (BE) studies, which assess the drug’s absorption and systemic exposure.

Q: Do any foods or supplements interact with Voltaren Gel?

Official warnings state that consuming alcohol while using this medicine may increase the risk of developing stomach ulcers. Interactions with typical foods and most common supplements are not generally noted in the core drug labeling.

Q: Can Voltaren Gel be used on the face or scalp?

The gel is specifically approved for use on certain joints of the upper and lower extremities. Regulatory warnings specify that contact with sensitive areas like the eyes, nose, or mouth should be avoided.

Q: Does the product label mention use for back pain?

The product is indicated for the relief of pain of osteoarthritis in joints that are close to the skin's surface, such as the hands and knees. Regulatory labeling notes that the product has not been evaluated for use on deeper joints, such as the spine or hip.

Q: Does the gel have a strong smell?

The product contains inactive ingredients, including isopropyl alcohol and strong ammonia solution. These components may contribute to a noticeable odor upon application.

Q: Does Voltaren Gel cause drowsiness?

Drowsiness and dizziness are listed as possible systemic side effects associated with the active ingredient. This is a potential reaction that applies to all medicines in the NSAID class.

Q: What is the difference in concentration between different brands of diclofenac gel?

Different concentrations of diclofenac topical gel are approved for various conditions. For instance, the 1% concentration is typically approved for osteoarthritis pain, while other concentrations (e.g., 3%) are approved for different specific uses.

Q: What are the official rules about how much gel is too much?

Official rules for administration include the use of a provided dosing card to measure the exact amount for each joint. The total quantity of gel used across all treated areas is subject to a maximum daily amount, as specified in the official labeling.

Q: Are there different active ingredients in Voltaren products other than the gel?

While the topical gel formulation contains diclofenac sodium, other products marketed under the same family name may contain different active forms, such as diclofenac diethylamine.

How should Voltaren Gel be stored and disposed of?

Storage and Disposal Requirements for Voltaren Gel

Voltaren Gel (diclofenac sodium topical gel) must be stored at Controlled Room Temperature, specifically between 20 to 25 C (68 to 77 F). Official labeling mandates that the gel must be kept from freezing and also protected from heat.

Requirement Official Stipulation
Temperature 20 to 25 C (68 to 77 F)
Protection Do not freeze; Protect from heat.
Child Safety Keep out of the reach of children.

The enclosed dosing card should be stored with the gel. All unused or expired product must be disposed of in accordance with local requirements for pharmaceutical waste, following any specific instructions provided on the labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Voltaren Gel found in:

A-Z Index: